Cargando…
A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms
OBJECTIVES: Geffer effervescent granules (active ingredients: metoclopramide, dimethicone, and sodium bicarbonate) is an established over-the-counter medication available in Italy for the symptomatic treatment of hyperacidity (pain and/or heartburn) when accompanied by slowing of gastric transit, na...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968989/ https://www.ncbi.nlm.nih.gov/pubmed/35371486 http://dx.doi.org/10.1177/20503121221088815 |
_version_ | 1784679163385348096 |
---|---|
author | Alemanni, Matteo de Salvo, Raffaella Moroni, Barbara Ehret, Andreas |
author_facet | Alemanni, Matteo de Salvo, Raffaella Moroni, Barbara Ehret, Andreas |
author_sort | Alemanni, Matteo |
collection | PubMed |
description | OBJECTIVES: Geffer effervescent granules (active ingredients: metoclopramide, dimethicone, and sodium bicarbonate) is an established over-the-counter medication available in Italy for the symptomatic treatment of hyperacidity (pain and/or heartburn) when accompanied by slowing of gastric transit, nausea, aerophagia, and bloating, all symptoms that can occur in functional dyspepsia and can negatively impact individuals’ quality of life. The aim of this observational study was to explore the perceived benefits of, and consumer experience with, Geffer effervescent granules used for the symptomatic treatment of digestive disorders suggestive of functional dyspepsia under real-life conditions in Italy. METHODS: Adults (aged 35–65 years) experiencing symptoms suggestive of functional dyspepsia/indigestion at least once a month and who had used Geffer effervescent granules within the previous 6 months completed an online questionnaire eliciting information on symptom relief (speed of onset and duration) and quality of life. RESULTS: Geffer effervescent granules provided rapid onset of symptom relief, with 21% of respondents perceiving an effect within 10 min and 88% reporting an improvement in overall symptoms within 30 min. A similarly rapid onset of complete resolution of gastric pain/cramps, acidity, bloating, nausea, and bothersome fullness symptoms was reported by 65%–83% of respondents; 50%–59% of respondents were free from such symptoms for more than 3 h or until the next meal. Most participants (92%) reported that their quality of life improved when taking Geffer effervescent granules to treat hyperacidity symptoms. Overall, 95% of the respondents were satisfied with the effectiveness of Geffer effervescent granules on overall symptom relief. CONCLUSIONS: In Italian consumers with digestive disorders likely due to functional dyspepsia, Geffer effervescent granules was associated with rapid, complete, and durable relief of symptoms of gastric pain/cramps, acidity, bloating, nausea, and bothersome fullness; an improvement in quality of life; and a high level of consumer satisfaction. |
format | Online Article Text |
id | pubmed-8968989 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-89689892022-04-01 A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms Alemanni, Matteo de Salvo, Raffaella Moroni, Barbara Ehret, Andreas SAGE Open Med Original Research Article OBJECTIVES: Geffer effervescent granules (active ingredients: metoclopramide, dimethicone, and sodium bicarbonate) is an established over-the-counter medication available in Italy for the symptomatic treatment of hyperacidity (pain and/or heartburn) when accompanied by slowing of gastric transit, nausea, aerophagia, and bloating, all symptoms that can occur in functional dyspepsia and can negatively impact individuals’ quality of life. The aim of this observational study was to explore the perceived benefits of, and consumer experience with, Geffer effervescent granules used for the symptomatic treatment of digestive disorders suggestive of functional dyspepsia under real-life conditions in Italy. METHODS: Adults (aged 35–65 years) experiencing symptoms suggestive of functional dyspepsia/indigestion at least once a month and who had used Geffer effervescent granules within the previous 6 months completed an online questionnaire eliciting information on symptom relief (speed of onset and duration) and quality of life. RESULTS: Geffer effervescent granules provided rapid onset of symptom relief, with 21% of respondents perceiving an effect within 10 min and 88% reporting an improvement in overall symptoms within 30 min. A similarly rapid onset of complete resolution of gastric pain/cramps, acidity, bloating, nausea, and bothersome fullness symptoms was reported by 65%–83% of respondents; 50%–59% of respondents were free from such symptoms for more than 3 h or until the next meal. Most participants (92%) reported that their quality of life improved when taking Geffer effervescent granules to treat hyperacidity symptoms. Overall, 95% of the respondents were satisfied with the effectiveness of Geffer effervescent granules on overall symptom relief. CONCLUSIONS: In Italian consumers with digestive disorders likely due to functional dyspepsia, Geffer effervescent granules was associated with rapid, complete, and durable relief of symptoms of gastric pain/cramps, acidity, bloating, nausea, and bothersome fullness; an improvement in quality of life; and a high level of consumer satisfaction. SAGE Publications 2022-03-29 /pmc/articles/PMC8968989/ /pubmed/35371486 http://dx.doi.org/10.1177/20503121221088815 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Article Alemanni, Matteo de Salvo, Raffaella Moroni, Barbara Ehret, Andreas A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms |
title | A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms |
title_full | A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms |
title_fullStr | A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms |
title_full_unstemmed | A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms |
title_short | A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms |
title_sort | real-world evidence study evaluating geffer effervescent granules for the symptomatic relief of digestive symptoms |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968989/ https://www.ncbi.nlm.nih.gov/pubmed/35371486 http://dx.doi.org/10.1177/20503121221088815 |
work_keys_str_mv | AT alemannimatteo arealworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms AT desalvoraffaella arealworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms AT moronibarbara arealworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms AT ehretandreas arealworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms AT alemannimatteo realworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms AT desalvoraffaella realworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms AT moronibarbara realworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms AT ehretandreas realworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms |